CSG Stock’s AMX Promotion Fails to Mask the Wounds of a 60% Slide

CSG joins AMX index, stock up 2.5% but 60% below IPO. Q1 revenue up 13.8%, €17B order book. Half-year results on Aug 7 crucial.

The Czechoslovak Group’s entry into the AMX index on Monday handed shareholders a modest 2.51% bounce, pushing the stock to €14.63. But the tick-up does little to paper over the deeper damage: since its IPO in January 2026, the defence contractor has shed roughly 60% of its market value, a decline that leaves the equity trading just a few euros above its 52-week low of €13.65.

Index inclusion forced ETF managers and institutional investors to take positions, generating mechanical demand. That structural buying explains Monday’s modest gain, yet the broader technical picture remains fragile. The 50-day moving average of €17.42 still looms nearly 19% above the current price, and the relative strength index at 35.3 signals the stock is hovering on the cusp of oversold territory.

A fractured valuation against a sturdy operational base

The contradiction between price and performance is stark. In the first quarter of 2026, CSG posted revenue of €1.544 billion, a 13.8% year-on-year surge. Its defence systems unit was the standout, growing 26.5% in sales. Operating EBIT rose 8.7% to €372 million, yielding a margin of 24.1%. The order book swelled to €17 billion from €15 billion at the end of 2025, with a further €27 billion pipeline still under negotiation.

Management has reaffirmed its full-year guidance: revenue between €7.4 billion and €7.6 billion, an adjusted EBIT margin of 24% to 25%, and net debt capped at 1.3 times EBITDA by year-end. On paper, the numbers are strong enough to justify a far higher valuation than the market currently assigns.

New contracts and a product push on the Eurosatory stage

At the Eurosatory defence exhibition in Paris earlier this month, CSG unveiled its new “Trident” air?defence system. Its subsidiary, AviaNera Technologies, struck a cooperation deal with Ukrainian Armor LLC to develop propulsion systems for missiles and unmanned platforms. Separately, the company secured a contract for munition fuzes valued in the high double?digit millions of euros.

Production capacity for large?calibre ammunition is on track to reach 850,000 units by the end of the year. Those output gains, if converted into margin improvement, could help restore investor confidence. But the market remains sceptical, and the annualised volatility of nearly 56% gives traders ample reason to stay cautious.

The half?year report as a potential turning point

The AMX promotion gives CSG a clearer spot in the Dutch equity landscape, yet the stock’s trajectory depends on execution, not index membership. The company must translate its €17 billion backlog into revenue and free cash flow at a convincing pace. The first real test arrives on 7 August, when the half?year results are due. Until then, the gap between a booming order book and a battered share price will remain the dominant narrative.